Dr. Mehrdad Abedi, MD
Claim this profileUC Davis Medical Center
Studies Lymphoma
Studies Hodgkin's Lymphoma
14 reported clinical trials
31 drugs studied
Affiliated Hospitals
Clinical Trials Mehrdad Abedi, MD is currently running
Tabelecleucel
for Post-Transplant Cancer
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab (SOT-R) and rituximab plus chemotherapy (SOT-R+C) or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.
Recruiting2 awards Phase 312 criteria
DSG3-CAART Cell Therapy
for Pemphigus Vulgaris
This trial is testing new cell therapies for patients with pemphigus vulgaris who don't respond to standard treatments. The therapies involve modifying the patient's own immune cells to better fight the disease and potentially provide long-term relief.
Recruiting1 award Phase 14 criteria
More about Mehrdad Abedi, MD
Clinical Trial Related7 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Mehrdad Abedi, MD has experience with
- Cyclophosphamide
- Tabelecleucel
- NXC-201
- Chimeric Antigen Receptor T-Cell Therapy
- Fludarabine Phosphate
- Rituximab
Breakdown of trials Mehrdad Abedi, MD has run
Hodgkin's Lymphoma
Cancer
Epstein-Barr Virus Infection
Lymphoproliferative Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mehrdad Abedi, MD specialize in?
Mehrdad Abedi, MD focuses on Lymphoma and Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved CD19 positive patients, or patients who are undergoing treatment.
Is Mehrdad Abedi, MD currently recruiting for clinical trials?
Yes, Mehrdad Abedi, MD is currently recruiting for 8 clinical trials in Sacramento California. If you're interested in participating, you should apply.
Are there any treatments that Mehrdad Abedi, MD has studied deeply?
Yes, Mehrdad Abedi, MD has studied treatments such as Cyclophosphamide, Tabelecleucel, NXC-201.
What is the best way to schedule an appointment with Mehrdad Abedi, MD?
Apply for one of the trials that Mehrdad Abedi, MD is conducting.
What is the office address of Mehrdad Abedi, MD?
The office of Mehrdad Abedi, MD is located at: UC Davis Medical Center, Sacramento, California 95817 United States. This is the address for their practice at the UC Davis Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.